Insider Trading & Ownership - Nichols Weston

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Nichols Weston
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-11-15
Purchase
2024-11-19
4:26 pm
TScan Therapeutics Inc.TCRXLynx1 Capital Management LP
Nichols Weston
10% Owner
947$4.3442$4,1145,225,547
(Indirect)
View
2023-05-31
Sale
2023-06-02
5:35 pm
TScan Therapeutics Inc.TCRXLynx1 Capital Management LP
Nichols Weston
10% Owner
25,400$2.5178$63,9535,224,600
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing

Ownership
2024-08-09
5:11 pm
N/A
N/A
Passage BIO Inc.PASGLynx1 Capital Management LP
Nichols Weston
10% Owner
0$08,426,955
(Indirect)
View
2024-06-07
Option Award
2024-06-11
4:20 pm
N/A
2034-06-07
Crinetics Pharmaceuticals Inc.CRNXNichols Weston
Director
15,900$021,900
(Direct)
View
2023-06-16
Option Award
2023-06-21
5:00 pm
N/A
2033-06-15
Crinetics Pharmaceuticals Inc.CRNXNichols Weston
Director
23,500$023,500
(Direct)
View

Ownership
2023-06-02
5:33 pm
N/A
N/A
TScan Therapeutics Inc.TCRXLynx1 Capital Management LP
Nichols Weston
10% Owner
0$05,250,000
(Indirect)
View
2022-06-17
Option Award
2022-06-21
4:46 pm
N/A
2032-06-16
Crinetics Pharmaceuticals Inc.CRNXNichols Weston
Director
17,500$017,500
(Direct)
View
2021-06-22
Option Award
2021-06-23
5:00 pm
N/A
2031-06-21
Crinetics Pharmaceuticals Inc.CRNXNichols Weston
Director
17,500$017,500
(Direct)
View
2020-06-19
Option Award
2020-06-22
4:20 pm
N/A
2030-06-18
Crinetics Pharmaceuticals Inc.CRNXNichols Weston
Director
12,500$012,500
(Direct)
View